Start experiments confidently with a reliable supply of ready-to-use, ethically sourced, human primary Th17 cells isolated from peripheral blood mononuclear cells (PBMCs). With personalized service, custom products, flexible delivery times, and the option to reserve entire lots to prescreen cells for applications, we help you get the cells you need.

Th17 cells (CD4+CXCR3-CCR6+) are isolated from PBMCs using positive immunomagnetic separation techniques to isolate particle-free CCR6+ cells, and unwanted cells are subsequently targeted for immunomagnetic depletion. Cells are obtained using Institutional Review Board (IRB)-approved consent forms and protocols, and cryopreserved in animal component-free CryoStor® CS10 medium. Additional documentation to meet institutional requirements and high-resolution HLA typing (Class I and Class II alleles) and CMV status is available upon request. Acid-citrate-dextrose solution A (ACDA) is added during collection as an anticoagulant.

Contact techsupport@stemcell.com for donor specifications (BMI category, smoking status, ethnicity, etc.). Donors are screened for HIV-1, HIV-2, hepatitis B, and hepatitis C. Certain products are only available in select territories.

Browse our frequently asked questions (FAQs) for additional information on our primary cell portfolio.